AIM
NNVC icon

Acrospire Investment Management’s NanoViricides NNVC Stock Holding History

Acrospire Investment Management’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-30
Closed -$1K – 2350
2016
Q3 		$1K Sell
30
-184
-86% -$6.1K ﹤0.01% 1934
2016
Q2 		$7K Buy
+214
New +$7.81K 0.01% 1813

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Acrospire Investment Management's NNVC Position: Q4 2016 in Review

Acrospire Investment Management sold out of NanoViricides (NNVC) in Q4 2016, closing a stake of 30 shares — an estimated $1K sold.

Acrospire Investment Management first reported a position in NNVC in Q2 2016 and held it in 2 quarters. The position peaked at $7K in Q2 2016. 44 funds tracked by Wall St. Rank hold NNVC as of Q4 2016.

  • Acrospire Investment Management reported no remaining NanoViricides position as of Q4 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 30 NanoViricides shares in Q4 2016, an estimated $1K.
  • Acrospire Investment Management first reported a position in NanoViricides in Q2 2016 and held it in 2 quarters.
  • Acrospire Investment Management's NanoViricides position peaked at $7K in Q2 2016.
  • 44 funds tracked by Wall St. Rank held NanoViricides as of Q4 2016.

Based on Acrospire Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.